Bactiguard Holding AB BACTI B
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 66.60
- Day Range
- SEK 66.60–69.20
- 52-Week Range
- SEK 49.50–95.00
- Bid/Ask
- SEK 68.00 / SEK 69.00
- Market Cap
- SEK 2.42 Bil
- Volume/Avg
- 47,179 / 9,676
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 11.44
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Bactiguard Holding AB is a Sweden-based medical device company. It is engaged in the development of infection prevention solutions, which reduce the risk of infections and the use of antibiotics. Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. Its portfolio contains urinary catheters, endotracheal tubes, central venous catheters, Hydrocyn for disinfection and wound care, as well as sutures and other wound care products. Its geographical segments are United States, Sweden, Malaysia, China, Thailand, Bangladesh, New Zeeland, and Other countries.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 219
- Website
- https://www.bactiguard.com
Comparables
Valuation
|
Metric
|
BACTI B
|
ELOS B
|
BONEX
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 67.42 |
Price/Book Value | 6.61 | 2.80 | 29.18 |
Price/Sales | 11.44 | — | 29.81 |
Price/Cash Flow | — | — | 525.42 |
Price/Earnings
BACTI B
ELOS B
BONEX
Financial Strength
|
Metric
|
BACTI B
|
ELOS B
|
BONEX
|
|---|---|---|---|
Quick Ratio | 2.07 | 0.40 | 2.99 |
Current Ratio | 2.55 | 1.99 | 4.03 |
Interest Coverage | −7.59 | 6.73 | 1.22 |
Quick Ratio
BACTI B
ELOS B
BONEX
Profitability
|
Metric
|
BACTI B
|
ELOS B
|
BONEX
|
|---|---|---|---|
Return on Assets (Normalized) | −16.26% | 7.39% | 53.88% |
Return on Equity (Normalized) | −27.58% | 13.33% | 69.96% |
Return on Invested Capital (Normalized) | −16.07% | 12.76% | 67.12% |
Return on Assets
BACTI B
ELOS B
BONEX
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Brxqzxxr | Kvttwd | $182.7 Bil | |
SYK
| Stryker Corp | Pymlqkcxq | Xhplh | $124.6 Bil | |
MDT
| Medtronic PLC | Wjfgnct | Rxdczg | $105.2 Bil | |
BSX
| Boston Scientific Corp | Srvfsfz | Jplnyv | $99.1 Bil | |
EW
| Edwards Lifesciences Corp | Wqnnymqmr | Dhdys | $52.0 Bil | |
DXCM
| DexCom Inc | Kqyzdfynrh | Gjd | $51.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Vxtdzxzlbn | Tdhcd | $24.5 Bil | |
ALGN
| Align Technology Inc | Jdvlvrfb | Tgksq | $22.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Nzddwmpp | Hczpgh | $18.3 Bil | |
PODD
| Insulet Corp | Qqtzssxvs | Hjhpfl | $11.6 Bil |